Beyond the Counter: Pharmacy’s New Guard Signals a Healthcare Revolution

📊 Key Data
  • 2026 Pharmacy EXPO: Recognized leaders driving a healthcare revolution in Canadian pharmacy.
  • Sector Catalyst Award: Honored innovators in underserved communities and specialty cancer care.
  • Expanding Scope: Pharmacists increasingly becoming primary care providers for minor ailments, immunizations, and chronic disease management.
🎯 Expert Consensus

Experts would likely conclude that the Canadian pharmacy sector is undergoing a transformative shift, with leaders driving innovation in patient access, specialization, and advocacy to address systemic healthcare challenges.

26 days ago
Beyond the Counter: Pharmacy’s New Guard Signals a Healthcare Revolution

Beyond the Counter: Pharmacy’s New Guard Signals a Healthcare Revolution

VANCOUVER, BC – June 03, 2026 – At the annual Pharmacy EXPO, amid the clinking glasses and formal accolades of the Chair's Dinner, the Neighbourhood Pharmacy Association of Canada did more than just honor its own. It drew a clear map of the future, recognizing a cohort of leaders whose work signals a fundamental restructuring of the pharmacy's role within the Canadian healthcare ecosystem. The awards ceremony wasn't merely a celebration; it was a strategic declaration, highlighting the innovators, advocates, and partners tasked with navigating a sector under immense pressure to evolve.

This year's gala was notable for the introduction of the Sandoz Canada-sponsored Sector Catalyst Award, a distinction created to honor “trailblazing leaders whose bold thinking…are accelerating change.” This move, alongside the presentation of legacy and partnership awards, underscores a dual strategy for survival and growth: radical innovation at the front lines of patient care, supported by a fortified business and advocacy structure at the core. The individuals celebrated represent the key pillars of this new architecture, moving the profession far beyond the traditional dispensing counter.

The Catalysts: Redefining Patient Access and Specialization

The inaugural Sector Catalyst Award, shared by two distinct leaders, points directly to the most urgent frontiers of pharmacy innovation: operational excellence in underserved communities and deep specialization in complex disease management. Alicia Matthews-Kent, Chief Operating Officer at Neighbourly Pharmacy, and Jason Wentzell, President & CEO of Extend Pharmacy Group, embody this push.

Matthews-Kent is being recognized for a mission-critical challenge in Canadian healthcare: bridging the urban-rural divide. Her work at Neighbourly Pharmacy focuses on advancing operational excellence to improve patient care and access, particularly in remote and underserved areas. Since her appointment as VP of Pharmacy in June 2023, she has been instrumental in leading the company's adaptation to an expanding scope of practice, where pharmacists are increasingly becoming primary points of care for minor ailments, immunizations, and chronic disease management. This isn't just about efficiency; it's a strategic response to a national healthcare system straining for access points. By developing high-performing healthcare teams and robust clinical programs, Matthews-Kent is engineering a model where the community pharmacy becomes a vital healthcare hub, especially where doctors are scarce.

On the other end of the spectrum is Jason Wentzell, whose work tackles the growing complexity of modern medicine. He founded Extend Pharmacy Group in 2019 to address a critical gap in oncology care. As more cancer treatments shift to take-home oral medications, patients are often left to navigate complex regimens with limited support between hospital visits. Wentzell’s Extend Cancer Pharmacy Network provides that missing link: a specialized service offering medication education, personalized consultations, and dedicated support for oncology patients. This entrepreneurial venture into specialty cancer care pharmacy is a prime example of how the sector can create new value propositions. It moves the pharmacist from a generalist to a specialized, integrated member of a patient’s oncology team, improving outcomes and demonstrating a new model for high-acuity community care.

Fortifying the Foundation: The Power of Advocacy and Alliance

While innovators like Matthews-Kent and Wentzell push the boundaries, the long-term viability of the pharmacy sector rests on a stable and sustainable business environment. The Association’s highest honors were reserved for two figures central to building that foundation.

Bruce Winston, Senior Director of Pharmacy Advocacy & Professional Affairs at Neighbourly Pharmacy, received the Len Marks Pharmacy Advancement Award for legacy leadership. An entrepreneur who co-founded and grew Apex Pharmacies before its acquisition by Neighbourly, Winston has spent his career championing the business of pharmacy. His work in advocacy, including his time as President of the Alberta Pharmacists' Association, is a testament to the relentless effort required to ensure the profession is recognized and compensated for its expanding role. This award highlights that innovation at the counter is unsustainable without powerful advocacy in the halls of government and with payers. It’s the story behind the story: for every new clinical service offered, a leader like Winston has fought for the regulatory and financial framework to make it possible.

Equally critical is the role of strategic partnerships, recognized through the Distinguished Partner of the Year Award presented to Michel Robidoux, President and General Manager of Sandoz Canada. Under Robidoux's decade-plus leadership, Sandoz has become a powerhouse in generic and biosimilar medicines, but his influence extends far beyond product supply. His active leadership in organizations like the Canadian Generic Pharmaceutical Association (CGPA) and Biosimilar Canada places him at the center of national debates on drug shortages, pharmacare, and healthcare sustainability. Sandoz's sponsorship of the new Sector Catalyst Award is a telling strategic move, aligning the pharmaceutical giant with the very forces of innovation it needs to thrive. The award to Robidoux signifies that the relationship between pharmacy and its suppliers has evolved from transactional to a deeply integrated alliance, essential for navigating a volatile supply chain and shaping national health policy.

A Sector Responding to Systemic Pressure

Taken together, the 2026 award recipients paint a picture of a sector in dynamic response to immense external pressures. As Neighbourhood Pharmacies CEO Sandra Hanna noted, they “reflect the spirit of progress and transformation happening across the sector.” This transformation is not optional. It's a necessary reaction to a healthcare system demanding more accessible, cost-effective, and specialized patient care. The expansion of pharmacist scope, the rise of specialty medicine, and the persistent challenge of rural healthcare access are the market forces driving the changes celebrated in Vancouver.

Board Chair Marie-Claude Vézina's hope for a “stronger, more sustainable future for pharmacy” hinges on the success of these intertwined strategies. The work of Matthews-Kent and Wentzell represents the sector's offensive strategy—creating new value and expanding its clinical footprint. The contributions of Winston and Robidoux represent the defensive strategy—protecting the economic and political viability of the entire enterprise. The Pharmacy EXPO, as the nation's sole event dedicated to the sector, serves as the annual forum where these strategies are refined and disseminated, bringing together retailers, suppliers, and leaders to align on the path forward. These awards, then, are more than just recognition; they are a public endorsement of the leaders and the business models deemed most critical for the future of the firm.

Sector: Pharmaceuticals Health IT Biotechnology Management Consulting
Theme: Telehealth & Digital Health Value-Based Care Sustainability & Climate Geopolitics & Trade
Event: Industry Conference Corporate Action
Product: Biosimilars
Metric: Revenue EBITDA
UAID: 33351